Global Saliva-based Screening Market Opportunities and Forecast 2022-2028

Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Saliva-based Screening Market Status and Forecast (2017-2028)
        1.3.2 Global Saliva-based Screening Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Saliva-based Screening Supply by Company
    2.1 Global Saliva-based Screening Sales Value by Company
    2.2 Saliva-based Screening Sales Area of Main Manufacturers
    2.3 Trend of Concentration Rate
3 Global and Regional Saliva-based Screening Market Status by Type
    3.1 Saliva-based Screening Type Introduction
        3.1.1 Direct Sample to PCR

        3.1.2 RT-qPCR

        3.1.3 Lateral Flow Assays

    3.2 Global Saliva-based Screening Market by Type
    3.3 North America: by Type
    3.4 Europe: by Type
    3.5 Asia Pacific: by Type
    3.6 Central & South America: by Type
    3.7 Middle East & Africa: by Type
4 Global and Regional Saliva-based Screening Market Status by Application
    4.1 Saliva-based Screening Segment by Application
        4.1.1 Diagnostic Laboratories

        4.1.2 Hospitals & Clinics

        4.1.3 Others

    4.2 Global Saliva-based Screening Market by Application
    4.3 North America: by Application
    4.4 Europe: by Application
    4.5 Asia Pacific: by Application
    4.6 Central & South America: by Application
    4.7 Middle East & Africa: by Application
5 Global Saliva-based Screening Market Status by Region
    5.1 Global Saliva-based Screening Market by Region
    5.2 North America Saliva-based Screening Market Status
    5.3 Europe Saliva-based Screening Market Status
    5.4 Asia Pacific Saliva-based Screening Market Status
    5.5 Central & South America Saliva-based Screening Market Status
    5.6 Middle East & Africa Saliva-based Screening Market Status
6 North America Saliva-based Screening Market Status
    6.1 North America Saliva-based Screening Market by Country
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Saliva-based Screening Market Status
    7.1 Europe Saliva-based Screening Market by Country
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Saliva-based Screening Market Status
   8.1 Asia Pacific Saliva-based Screening Market by Country
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Saliva-based Screening Market Status
    9.1 Central & South America Saliva-based Screening Market by Country
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Saliva-based Screening Market Status
    10.1 Middle East & Africa Saliva-based Screening Market by Country
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Major Downstream Customers Analysis
    11.1 Customer One Analysis
    11.2 Customer Two Analysis
    11.3 Customer Three Analysis
    11.4 Customer Four Analysis
12 Global Saliva-based Screening Market Forecast by Type and by Application
    12.1 Global Saliva-based Screening Sales Value Forecast (2023-2028)
    12.2 Global Saliva-based Screening Forecast by Type
    12.3 Global Saliva-based Screening Forecast by Application
13 Global Saliva-based Screening Market Forecast by Region/Country
    13.1 Global Saliva-based Screening Market Forecast by Region (2023-2028)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 Zymo Research Corporation.

        14.1.1 Company Information
        14.1.2 Saliva-based Screening Product Introduction
        14.1.3 Zymo Research Corporation.
 Saliva-based Screening Sales Value, Gross Margin and Global Share (2020-2022)
        14.1.4 SWOT Analysis
    14.2 Vitagene

        14.2.1 Company Information
        14.2.2 Saliva-based Screening Product Introduction
        14.2.3 Vitagene
 Saliva-based Screening Sales Value, Gross Margin and Global Share (2020-2022)
        14.2.4 SWOT Analysis
    14.3 TODA PHARMA

        14.3.1 Company Information
        14.3.2 Saliva-based Screening Product Introduction
        14.3.3 TODA PHARMA
 Saliva-based Screening Sales Value, Gross Margin and Global Share (2020-2022)
        14.3.4 SWOT Analysis
    14.4 Thermo Fisher scientific

        14.4.1 Company Information
        14.4.2 Saliva-based Screening Product Introduction
        14.4.3 Thermo Fisher scientific
 Saliva-based Screening Sales Value, Gross Margin and Global Share (2020-2022)
        14.4.4 SWOT Analysis
    14.5 Therma Bright Inc

        14.5.1 Company Information
        14.5.2 Saliva-based Screening Product Introduction
        14.5.3 Therma Bright Inc
 Saliva-based Screening Sales Value, Gross Margin and Global Share (2020-2022)
        14.5.4 SWOT Analysis
    14.6 Takara Bio Inc

        14.6.1 Company Information
        14.6.2 Saliva-based Screening Product Introduction
        14.6.3 Takara Bio Inc
 Saliva-based Screening Sales Value, Gross Margin and Global Share (2020-2022)
        14.6.4 SWOT Analysis
    14.7 Salimetrics

        14.7.1 Company Information
        14.7.2 Saliva-based Screening Product Introduction
        14.7.3 Salimetrics
 Saliva-based Screening Sales Value, Gross Margin and Global Share (2020-2022)
        14.7.4 SWOT Analysis
    14.8 Qiagen

        14.8.1 Company Information
        14.8.2 Saliva-based Screening Product Introduction
        14.8.3 Qiagen
 Saliva-based Screening Sales Value, Gross Margin and Global Share (2020-2022)
        14.8.4 SWOT Analysis
    14.9 Norgen Biotek Corp.

        14.9.1 Company Information
        14.9.2 Saliva-based Screening Product Introduction
        14.9.3 Norgen Biotek Corp.
 Saliva-based Screening Sales Value, Gross Margin and Global Share (2020-2022)
        14.9.4 SWOT Analysis
    14.10 NeuMoDx Molecular, Inc.

        14.10.1 Company Information
        14.10.2 Saliva-based Screening Product Introduction
        14.10.3 NeuMoDx Molecular, Inc.
 Saliva-based Screening Sales Value, Gross Margin and Global Share (2020-2022)
        14.10.4 SWOT Analysis
    14.11 NEST Scientific USA

    14.12 Nantong Diagnos Biotechnology Co., Ltd

    14.13 Miraclean Technology Co. Ltd

    14.14 Mawi DNA Technologies

    14.15 Lucence Health INc

    14.16 KYODO INTERNATIONAL INC.

    14.17 Kolplast Group

    14.18 Hologic

    14.19 GeneProof

    14.20 Chai Inc.

    14.21 Cell Projects Ltd.

    14.22 Canvax

    14.23 Beijing Hotgen Biotech Co., Ltd

    14.24 Assure Tech. (Hangzhou) Co., Ltd

    14.25 Arcis Biotechnology Limited

    14.26 ACON Laboratories, Inc

    14.27 Abacus ALS

15 Conclusion
16 Methodology